[4] Fierce Pharma: Moderna's new booster launch tripped up by production issues at Catalent plant: reports [5] Fierce Pharma: No more free COVID vaccines: US plots move to private market in 2023, setting up market clash between Pfizer and Moderna [6] Being 科学:《Moderna从诺华再挖一名高...
参考资料: [1] WHO. WHO Coronavirus (COVID-19) Dashboard, covid19.who.int. Retrieved 12 October 2021. [2]Wu, Kai, et al. "Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice." bioRxiv (2021b). [3]Qu, Liang, et al. "Circular RNA v...
New CDC website shows if COVID or flu is on the rise in 2024 More In: Booster Dose COVID-19 Vaccine COVID-19 Vaccines Haley Ott Haley Ott is the CBS News Digital international reporter, based in the CBS News London bureau. TwitterInstagram...
The US drug company Moderna has announced that it is developing two new approaches to emerging variants of covid-19 after studies showed that its vaccine had a reduced level of neutralising titres to the South African variant, suggesting that immunity might wane. Although the studies showed that...
The objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomized, open-label study. Eligible adults aged ≥ 18...
“The dramatic increase in Covid-19 cases from the omicron variant is concerning to all,” Moderna CEO Stéphane Bancel said in a statement. “However, these data showing that the currently authorized Moderna Covid-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost ...
WASHINGTON, Dec. 20 (Xinhua) -- American biotechnology company Moderna announced Monday that preliminary data suggests its COVID-19 booster shot appears to increase antibody levels against the Omicron coronavirus variant. The currently authorized 50-microgram booster of Moderna's COVID-19 vaccine mRNA...
The Food and Drug Administration on Wednesday gave the companies the go-ahead to roll out their “bivalent” shots, which target both the original strain of Covid and the fast-spreading BA.4 and BA.5 subvariants, ahead...
When will you get the COVID-19 vaccine? "Out of an abundance of caution and leveraging the flexibility of our mRNA platform, we are advancing an emerging variant booster candidate against the variant first identified in the Republic of South Africa into the clinic." ...
- Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, the company said it believes a booster dose will be necessary prior to the winter season. The company a...